Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371345
Status:
COMPLETED
Last Update Posted:
2011-04-26
First Post:
2006-09-01
Brief Title:
Study of Dasatinib BMS-354825 in Patients With Advanced EstrogenProgesterone Receptor-positive ERPR or Her2Neu-positive Her2NeuBreast Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastasis |
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Recurrent locally-advanced or metastatic breast cancer | View |